Hope for Alzheimer’s Patients
Hearing the words "cure" and "Alzheimer's" together in the same sentence would be a medical miracle for the five million Americans living everyday with this devastating condition. In the meantime, the national institute on aging will soon recruit a small number of patients to test a new drug that researchers hope will reverse the damage that Alzheimer's has already done. "What we've been studying is a new medicine that helps the brain to recover from injury," said Sam Gandy, M.D., PhD, Director of the Center for Cognitive Health at the Icahn School of Medicine at Mount Sinai.
- Dr. Samuel Gandy, Professor, Neurology, Psychiatry, Mount Sinai Professor in Alzheimer's Research, Icahn School of Medicine at Mount Sinai

Mount Sinai Launches AI Small Molecule Drug Discovery Center
Apr 02, 2025 View All Press Releases